Q32M21
Gene name |
Gsdma2 |
Protein name |
Gasdermin-A2 |
Names |
Gasdermin-2 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:76758 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
3-233 (N-terminal gasdermin domain) |
Relief mechanism |
Cleavage |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q32M21
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q32M21-F1 | Predicted | AlphaFoldDB |
48 variants for Q32M21
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs244620717 | 2 | S>P | No | Ensembl | |
rs244620717 | 2 | S>T | No | Ensembl | |
rs580388776 | 6 | D>N | No | Ensembl | |
rs264762506 | 12 | A>V | No | Ensembl | |
rs229266266 | 14 | Q>E | No | Ensembl | |
rs259542803 | 18 | R>Q | No | Ensembl | |
rs582900366 | 28 | I>M | No | Ensembl | |
rs27059399 | 55 | R>H | No | Ensembl | |
rs246204601 | 123 | T>M | No | Ensembl | |
rs27059396 | 147 | Y>H | No | Ensembl | |
rs217322197 | 167 | K>T | No | Ensembl | |
rs239673342 | 199 | K>M | No | Ensembl | |
rs247077233 | 211 | I>M | No | Ensembl | |
rs257156978 | 212 | I>V | No | Ensembl | |
rs582088992 | 217 | E>K | No | Ensembl | |
rs261745273 | 221 | P>S | No | Ensembl | |
rs218555340 | 222 | Y>H | No | Ensembl | |
rs235464998 | 227 | N>S | No | Ensembl | |
rs251461635 | 233 | P>H | No | Ensembl | |
rs220582463 | 236 | V>M | No | Ensembl | |
rs27059387 | 237 | L>P | No | Ensembl | |
rs27059386 | 241 | G>A | No | Ensembl | |
rs222694239 | 244 | V>A | No | Ensembl | |
rs240799727 | 246 | M>K | No | Ensembl | |
rs264867708 | 247 | I>L | No | Ensembl | |
rs581724432 | 258 | L>I | No | Ensembl | |
rs582645519 | 260 | K>E | No | Ensembl | |
rs578382460 | 262 | V>I | No | Ensembl | |
rs211960638 | 264 | Q>R | No | Ensembl | |
rs252528260 | 300 | M>T | No | Ensembl | |
rs579847012 | 309 | H>Q | No | Ensembl | |
rs583582660 | 312 | T>I | No | Ensembl | |
rs261457578 | 323 | L>S | No | Ensembl | |
rs587346533 | 326 | A>P | No | Ensembl | |
rs222363488 | 349 | V>I | No | Ensembl | |
rs579182722 | 358 | P>L | No | Ensembl | |
rs246546055 | 358 | P>S | No | Ensembl | |
rs255158090 | 378 | D>G | No | Ensembl | |
rs240549416 | 383 | R>Q | No | Ensembl | |
rs259500555 | 392 | E>K | No | Ensembl | |
rs231650341 | 394 | D>E | No | Ensembl | |
rs248853320 | 395 | Q>L | No | Ensembl | |
rs582636828 | 403 | G>E | No | Ensembl | |
rs231066910 | 419 | N>D | No | Ensembl | |
rs216479573 | 423 | C>R | No | Ensembl | |
rs228626841 | 426 | L>V | No | Ensembl | |
rs585312092 | 440 | S>G | No | Ensembl | |
rs27059365 | 441 | R>K | No | Ensembl |
1 associated diseases with Q32M21
Without disease ID
8 regional properties for Q32M21
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | AGC-kinase, C-terminal | 357 - 425 | IPR000961 |
domain | Pleckstrin homology domain | 1150 - 1351 | IPR001849 |
active_site | Serine/threonine-protein kinase, active site | 210 - 222 | IPR008271 |
domain | HR1 rho-binding domain | 497 - 573 | IPR011072 |
domain | ROCK, Rho binding domain | 978 - 1047 | IPR015008 |
binding_site | Protein kinase, ATP binding site | 98 - 121 | IPR017441 |
domain | Rho-associated protein kinase 2, catalytic domain | 39 - 417 | IPR029878 |
domain | Rho-associated protein kinase 2, HR1 domain | 505 - 571 | IPR037311 |
4 GO annotations of cellular component
Name | Definition |
---|---|
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
3 GO annotations of molecular function
Name | Definition |
---|---|
phosphatidylinositol-4,5-bisphosphate binding | Binding to phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions. |
phosphatidylinositol-4-phosphate binding | Binding to phosphatidylinositol-4-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' position. |
phosphatidylserine binding | Binding to phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine. |
3 GO annotations of biological process
Name | Definition |
---|---|
apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
defense response to bacterium | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. |
pyroptosis | A caspase-1-dependent cell death subroutine that is associated with the generation of pyrogenic mediators such as IL-1beta and IL-18. |
12 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P57764 | GSDMD | Gasdermin-D | Homo sapiens (Human) | EV |
Q9BYG8 | GSDMC | Gasdermin-C | Homo sapiens (Human) | SS |
Q96QA5 | GSDMA | Gasdermin-A | Homo sapiens (Human) | SS |
Q8TAX9 | GSDMB | Gasdermin-B | Homo sapiens (Human) | EV |
Q8CB12 | Gsdmc3 | Gasdermin-C3 | Mus musculus (Mouse) | SS |
Q2KHK6 | Gsdmc2 | Gasdermin-C2 | Mus musculus (Mouse) | SS |
Q3TR54 | Gsdmc4 | Gasdermin-C4 | Mus musculus (Mouse) | SS |
Q99NB5 | Gsdmc | Gasdermin-C | Mus musculus (Mouse) | SS |
Q9D8T2 | Gsdmd | Gasdermin-D | Mus musculus (Mouse) | SS |
Q5Y4Y6 | Gsdma3 | Gasdermin-A3 | Mus musculus (Mouse) | EV |
Q9EST1 | Gsdma | Gasdermin-A | Mus musculus (Mouse) | SS |
P85967 | Gsdmc | Gasdermin-C | Rattus norvegicus (Rat) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MSMFEDVTRA | LARQLNPRGD | LTPLDSLIDF | KRFHPFCLVL | RKRKSTLFWG | ARYVRTDYTL |
70 | 80 | 90 | 100 | 110 | 120 |
LDVLEPGSSP | SDPTLLGNFS | FKNMLDVRVE | GDVEVPTMMK | VKGTVGLSQS | STLEVQMLSV |
130 | 140 | 150 | 160 | 170 | 180 |
APTALENLHM | ERKLSADHPF | LKEMREYKQN | LYVVMEVVKA | KQEVTLKRAS | NAISKFSLNL |
190 | 200 | 210 | 220 | 230 | 240 |
PSLGLQGSVN | HKEAVTIPKG | CVLAYRVRQL | IIYGKDEWGI | PYICTDNMPT | FNPLCVLQRQ |
250 | 260 | 270 | 280 | 290 | 300 |
GSTVQMISGE | MHEDFKTLKK | EVQQETQEVE | KLSPVGRSSL | LTSLSHLLGK | KKELQDLEQM |
310 | 320 | 330 | 340 | 350 | 360 |
LEGALDKGHE | VTLEALPKDV | LLLKDAMDAI | LYFLGALTEL | SEEQLKILVK | SLENKVLPVQ |
370 | 380 | 390 | 400 | 410 | 420 |
LKLVESILEQ | NFLQDKEDVF | PLRPDLLSSL | GEEDQILTEA | LVGLSGLEVQ | RSGPQYTWNP |
430 | 440 | ||||
DTCHNLCALY | AGLSLLHLLS | RDS |